MeSH Review:
Sarcoma
- The use of neutron beam therapy in the management of locally advanced nonresectable radioresistant tumors. Hendrickson, F.R. CA: a cancer journal for clinicians. (1988)
- Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Chen, W.Y., Zeng, X., Carter, M.G., Morrell, C.N., Chiu Yen, R.W., Esteller, M., Watkins, D.N., Herman, J.G., Mankowski, J.L., Baylin, S.B. Nat. Genet. (2003)
- The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Murray, M.J., Cunningham, J.M., Parada, L.F., Dautry, F., Lebowitz, P., Weinberg, R.A. Cell (1983)
- Transforming proteins of some feline and avian sarcoma viruses are related structurally and functionally. Beemon, K. Cell (1981)
- Interaction between the retinoblastoma protein and the oncoprotein MDM2. Xiao, Z.X., Chen, J., Levine, A.J., Modjtahedi, N., Xing, J., Sellers, W.R., Livingston, D.M. Nature (1995)
- Burn scar neoplasms: a literature review and statistical analysis. Kowal-Vern, A., Criswell, B.K. Burns : journal of the International Society for Burn Injuries. (2005)
- Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. St John, M.A., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M.L., Brownstein, D.G., Parlow, A.F., McGrath, J., Xu, T. Nat. Genet. (1999)
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Lee, S.B., Kolquist, K.A., Nichols, K., Englert, C., Maheswaran, S., Ladanyi, M., Gerald, W.L., Haber, D.A. Nat. Genet. (1997)
- Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. Toguchida, J., Yamaguchi, T., Dayton, S.H., Beauchamp, R.L., Herrera, G.E., Ishizaki, K., Yamamuro, T., Meyers, P.A., Little, J.B., Sasaki, M.S. N. Engl. J. Med. (1992)
- Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fingerhut, M.A., Halperin, W.E., Marlow, D.A., Piacitelli, L.A., Honchar, P.A., Sweeney, M.H., Greife, A.L., Dill, P.A., Steenland, K., Suruda, A.J. N. Engl. J. Med. (1991)
- The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Roy, L.M., Singh, B., Gautier, J., Arlinghaus, R.B., Nordeen, S.K., Maller, J.L. Cell (1990)
- Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid. Miskin, R., Easton, T.G., Reich, E. Cell (1978)
- Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity. Weinmaster, G., Zoller, M.J., Smith, M., Hinze, E., Pawson, T. Cell (1984)
- Thoracic soft-tissue sarcoma in Vietnam veterans exposed to Agent Orange. Sarma, P.R., Jacobs, J. N. Engl. J. Med. (1982)
- Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Wilson, E.L., Reich, E. Cell (1978)
- Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice. Hellström, I., Hellström, K.E. Nature (1978)
- Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. Benz, M.R., Evilevitch, V., Allen-Auerbach, M.S., Eilber, F.C., Phelps, M.E., Czernin, J., Weber, W.A. J. Nucl. Med. (2008)
- Characterization of protein kinase activity associated with the transforming gene product of Fujinami sarcoma virus. Feldman, R.A., Hanafusa, T., Hanafusa, H. Cell (1980)
- Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras. Bateman, W.J., Fiera, R., Matthews, N., Morris, A.G. J. Exp. Med. (1991)
- Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma. Pravtcheva, D.D., DeLeo, A.B., Ruddle, F.H., Old, L.J. J. Exp. Med. (1981)
- BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell. Pierce, J.H., Aaronson, S.A. J. Exp. Med. (1982)
- Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests. Bubeník, J., Indrová, M., Nemecková, S., Malkovský, M., Von Broen, B., Pálek, V., Anderlíková, J. Int. J. Cancer. (1978)
- Expression of the gene for tumor necrosis factor-beta but not for tumor necrosis factor-alpha is impaired in tumor-bearing mice. Lipoldová, M., Zajícová, A., Holán, V. Cell. Immunol. (1993)
- Interleukin-1 production by immunologically hyporeactive tumour-bearing mice. Holán, V., Lipoldová, M. Br. J. Cancer. (1990)
- Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor. Holán, V., Lipoldová, M. Immunology. (1990)
- Low responsiveness of spleen cells from tumour-bearing mice to recombinant interleukin-1 and interleukin-2. Impaired expression of interleukin-2 receptors. Holán, V., Lipoldová, M. Int. J. Cancer. (1990)
- Localization of serum-derived alpha 2 macroglobulin in cultured cells and decrease after Moloney sarcoma virus transformation. Pastan, I., Willingham, M., Anderson, W., Gallo, M. Cell (1977)
- A ras-related gene with transformation suppressor activity. Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., Noda, M. Cell (1989)
- Coexistence of three major isoactins in a single sarcoma 180 cell. Bravo, R., Fey, S.J., Small, J.V., Larsen, P.M., Celis, J.E. Cell (1981)
- Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Mulé, J.J., Shu, S., Schwarz, S.L., Rosenberg, S.A. Science (1984)
- A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability. Restifo, N.P., Spiess, P.J., Karp, S.E., Mulé, J.J., Rosenberg, S.A. J. Exp. Med. (1992)
- The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous. Struhl, K. Cell (1987)
- Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Jones, S.N., Roe, A.E., Donehower, L.A., Bradley, A. Nature (1995)
- Mouse tumor model for neurofibromatosis type 1. Vogel, K.S., Klesse, L.J., Velasco-Miguel, S., Meyers, K., Rushing, E.J., Parada, L.F. Science (1999)
- Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. Barr, F.G., Chatten, J., D'Cruz, C.M., Wilson, A.E., Nauta, L.E., Nycum, L.M., Biegel, J.A., Womer, R.B. JAMA (1995)
- Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. Mulé, J.J., Smith, C.A., Rosenberg, S.A. J. Exp. Med. (1987)
- A spatially and temporally restricted mouse model of soft tissue sarcoma. Kirsch, D.G., Dinulescu, D.M., Miller, J.B., Grimm, J., Santiago, P.M., Young, N.P., Nielsen, G.P., Quade, B.J., Chaber, C.J., Schultz, C.P., Takeuchi, O., Bronson, R.T., Crowley, D., Korsmeyer, S.J., Yoon, S.S., Hornicek, F.J., Weissleder, R., Jacks, T. Nat. Med. (2007)
- A three-gene signature for outcome in soft tissue sarcoma. Hoffmann, A.C., Hoffman, A.C., Danenberg, K.D., Taubert, H., Danenberg, P.V., Wuerl, P. Clin. Cancer Res. (2009)
- Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Willingham, M.C., Pastan, I., Shih, T.Y., Scolnick, E.M. Cell (1980)
- Heat shock protein 70-associated peptides elicit specific cancer immunity. Udono, H., Srivastava, P.K. J. Exp. Med. (1993)
- Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group. Bramwell, V., Quirt, I., Warr, D., Verma, S., Young, V., Knowling, M., Eisenhauer, E. J. Natl. Cancer Inst. (1989)
- Effects of postoperative adjuvant chemotherapy and radiotherapy on ovarian function in women undergoing treatment for soft tissue sarcoma. Shamberger, R.C., Sherins, R.J., Ziegler, J.L., Glatstein, E., Rosenberg, S.A. J. Natl. Cancer Inst. (1981)
- Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity. Merchant, M.S., Woo, C.W., Mackall, C.L., Thiele, C.J. J. Natl. Cancer Inst. (2002)